In this study, B220+CD11c+NK1.1+ cells showed an anti‐metastatic activity by eliminating fibrinogen in a FX‐dependent manner in the pre‐metastatic phase and by killing tumour cells in the post‐metastatic phase. The gene discussed is ITGAX; the disease is neoplasm.